Atıf Formatları
Dual inhibition of Wnt/beta-catenin signaling and histone deacetylation as a new strategy to eliminate breast cancer stem cells by augmentation of apoptosis
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

N. AZTOPAL Et Al. , "Dual inhibition of Wnt/beta-catenin signaling and histone deacetylation as a new strategy to eliminate breast cancer stem cells by augmentation of apoptosis," FEBS OPEN BIO , vol.8, pp.301, 2018

AZTOPAL, N. Et Al. 2018. Dual inhibition of Wnt/beta-catenin signaling and histone deacetylation as a new strategy to eliminate breast cancer stem cells by augmentation of apoptosis. FEBS OPEN BIO , 301.

AZTOPAL, N., Merve, E., ARI, F., DERE, E., & ULUKAYA, E., (2018). Dual inhibition of Wnt/beta-catenin signaling and histone deacetylation as a new strategy to eliminate breast cancer stem cells by augmentation of apoptosis . FEBS OPEN BIO (pp.301).

AZTOPAL, NAZLIHAN Et Al. "Dual inhibition of Wnt/beta-catenin signaling and histone deacetylation as a new strategy to eliminate breast cancer stem cells by augmentation of apoptosis," FEBS OPEN BIO, 2018

AZTOPAL, NAZLIHAN Et Al. "Dual inhibition of Wnt/beta-catenin signaling and histone deacetylation as a new strategy to eliminate breast cancer stem cells by augmentation of apoptosis." FEBS OPEN BIO , pp.301, 2018

AZTOPAL, N. Et Al. (2018) . "Dual inhibition of Wnt/beta-catenin signaling and histone deacetylation as a new strategy to eliminate breast cancer stem cells by augmentation of apoptosis." FEBS OPEN BIO , p.301.

@conferencepaper{conferencepaper, author={NAZLIHAN AZTOPAL Et Al. }, title={Dual inhibition of Wnt/beta-catenin signaling and histone deacetylation as a new strategy to eliminate breast cancer stem cells by augmentation of apoptosis}, congress name={FEBS OPEN BIO}, city={}, country={}, year={2018}, pages={301} }